SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-035232
Filing Date
2019-07-19
Accepted
2019-07-19 17:11:57
Documents
47
Period of Report
2019-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv525270_10q.htm 10-Q 301972
2 EXHIBIT 31.1 tv525270_ex31-1.htm EX-31.1 10728
3 EXHIBIT 32.1 tv525270_ex32-1.htm EX-32.1 4568
  Complete submission text file 0001144204-19-035232.txt   2584120

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT qbio-20190531.xml EX-101.INS 625210
5 XBRL TAXONOMY EXTENSION SCHEMA qbio-20190531.xsd EX-101.SCH 23660
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qbio-20190531_cal.xml EX-101.CAL 19806
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qbio-20190531_def.xml EX-101.DEF 93105
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE qbio-20190531_lab.xml EX-101.LAB 198568
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qbio-20190531_pre.xml EX-101.PRE 174887
Mailing Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017
Business Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017 212-588-0022
Q BioMed Inc. (Filer) CIK: 0001596062 (see all company filings)

IRS No.: 464013793 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 10-Q | Act: 34 | File No.: 000-55535 | Film No.: 19964092
SIC: 2834 Pharmaceutical Preparations